Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
ADVERTISEMENT

Vaccines

Adenoviral vector vaccine data both promising and perplexing

Preliminary results from AstraZeneca and Oxford’s Phase 3 trial of their COVID-19 vaccine suggest a smaller dose is better than a full dose

Biologics

Merck makes third COVID-19 acquisition

OncoImmune’s immune modulator is the third COVID-19 related acquisition for the pharma giant

ADVERTISEMENT
image name
Policy

Biden picks climate action advocates for top jobs

President-elect taps former secretary of state and Federal Reserve chair


Trichloroethylene poses health risks, US EPA confirms

Agency finds unreasonable risks to workers and consumers for nearly all uses evaluated

image name
Obituaries

Catalysis researcher John M. Thomas dies

Cambridge scientist advanced transmission electron microscopy methods for imaging catalytic nanomaterials


image name
Inorganic Chemistry

Alternative materials could shrink concrete’s giant carbon footprint

Making cement releases 8% of the world’s anthropogenic CO₂. New formulations could slash that number


Nanofibers put a new spin on COVID-19 masks

Start-ups are using nanofibers created by electrospinning to make better face masks